Literature DB >> 9029413

CSF inositol does not predict antidepressant response to inositol. Short communication.

J Levine1, L Kurtzman, A Rapoport, J Zimmerman, Y Bersudsky, J Shapiro, R H Belmaker, G Agam.   

Abstract

CSF inositol was reported to be reduced in depression and inositol has been reported to be effective in treatment of depression. We studied CSF inositol in 18 drug-free depressed patients and 36 normal controls; the depressed patients then participated in an open trial of 18 gm daily inositol treatment for 4 weeks. There was no difference in pre-treatment CSF inositol between depressed patients and controls. CSF inositol levels did not predict response on the Hamilton Depression Scale to 4 weeks of inositol treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9029413     DOI: 10.1007/BF01271260

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  9 in total

1.  Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder.

Authors:  A I Barkai; D L Dunner; H A Gross; P Mayo; R R Fieve
Journal:  Biol Psychiatry       Date:  1978-02       Impact factor: 13.382

2.  Inositol treatment raises CSF inositol levels.

Authors:  J Levine; A Rapaport; L Lev; Y Bersudsky; O Kofman; R H Belmaker; J Shapiro; G Agam
Journal:  Brain Res       Date:  1993-11-05       Impact factor: 3.252

3.  Behavioral evidence for the existence of two pools of cellular inositol.

Authors:  Y Bersudsky; Z Kaplan; Y Shapiro; G Agam; O Kofman; R H Belmaker
Journal:  Eur Neuropsychopharmacol       Date:  1994-12       Impact factor: 4.600

4.  CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia.

Authors:  J Levine; I Goldberger; A Rapaport; M Schwartz; C Schield; A Elizur; R H Belmaker; J Shapiro; G Agam
Journal:  Eur Neuropsychopharmacol       Date:  1994-12       Impact factor: 4.600

5.  Double-blind, controlled trial of inositol treatment of depression.

Authors:  J Levine; Y Barak; M Gonzalves; H Szor; A Elizur; O Kofman; R H Belmaker
Journal:  Am J Psychiatry       Date:  1995-05       Impact factor: 18.112

6.  High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium.

Authors:  G Agam; Y Shapiro; Y Bersudsky; O Kofman; R H Belmaker
Journal:  Pharmacol Biochem Behav       Date:  1994-10       Impact factor: 3.533

7.  Myo-inositol reduces serotonin (5-HT2) receptor induced homologous and heterologous desensitization.

Authors:  S Rahman; R S Neuman
Journal:  Brain Res       Date:  1993-12-24       Impact factor: 3.252

Review 8.  Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression.

Authors:  O Kofman; R H Belmaker
Journal:  Biol Psychiatry       Date:  1993-12-15       Impact factor: 13.382

9.  Polyol profiles in Down syndrome. myo-Inositol, specifically, is elevated in the cerebrospinal fluid.

Authors:  H U Shetty; M B Schapiro; H W Holloway; S I Rapoport
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

  9 in total
  1 in total

1.  Epi-inositol and inositol depletion: two new treatment approaches in affective disorder.

Authors:  Y Bersudsky; H Einat; Z Stahl; R H Belmaker
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.